Information profile @ a Glance
- Phosphate-binding therapy is considered integral to the
management of hyperphosphatemia in hemodialysis patients.
- Sevelamer Hydrochloride is a polymeric amine that binds phosphate
and is meant for oral administration
- Sevelamer Hydrochloride is a polycationpolymer and binds phosphorus
in the gastrointestinal tract to facilitate phosphorus excretion in
feces, thereby inhibiting phosphorus absorption from the gut, and
thereby lowering the plasma phosphorus
concentration
- Sevelamer reduced inpatient Medicare costs compared with calcium
binders. However, when binder costs
were added, overall PMPM costs favored calcium-treated over sevelamer-treated
participants
- There are at least indications that sevelamer may improve vascular
and bone health and, perhaps, mortality
in hemodialysis patients, whereas data on calcium-based binders are
lacking
- Lupin has entered in to settlement deal with Genzyme for
Sevelamer that prevents a crucial blood disorder in patients with
chronic renal failure. These products generated annual sales of USD700
million as per latest available data. As per settlement deal, Lupin
would be able to launch these products before patent expiry in August
2013.
|
Basic Information
-
Chronic Kidney Disease: Current Status,Challenges and
Management in India
-
Hyperphosphatemia
-
Hemodialysis - India
-
Kidney disease Statistics- USA
-
Economics of Sevelamer and Calcium-Based Phosphate
Binders in Hemodialysis Patients
-
Experience with Phosphate Binders
-
The product Patent Regime - India
-
Patients Undergoing Hemodialysis
-
Treatment of hyperphosphatemia
in Indian patients
-
Appraisal of sevelamer in the management of chronic
renal failure
-
Peritoneal Dialysis - India
Technology & applications
- Colesevelam Hydrochloride
- Product Monograph: sevelamer hydrochloride
- Consultant -Sevelamer: Comprehensive patent search
- Consultant - Sevelamer: Key patent, SPC, and data exclusivity expiry
- Product assessment : sevelamer carbonate
- Research & Development
- Research Article - colesevelam hcl
- Process for the preparation of Sevelamer Hydrocholoride
- Process for the preparation of Sevelamer Carbonate
- Process for the preparation of Colesevelam Hydrochloride
|
Trade Scenario
- Company & market share
- Kidney Disease Statistics for the United States
- Phosphate binders & Price factor
- Use and costs of phosphate binders
- The European marketing authorization
- Sevelamer Carbonate-Market
Research consultant
- Listing for the treatment of hyperphosphataemia
- Drug Price Listing
- The shared care guideline
- Sample Tender - India
- Sample tender - India
Companies & Products
-
Company - India
-
Company - India
-
Sevelamer - msds
-
Colesevelam - msds
Companies & Performances
- Performance of Companies in Health Care - India
- Special Packaging Requirements
- Company Annual Report -Switzerland
- Indian Company - annual report
- Company Presentation - Business Outlook
- Company - Red Herring Prospectus
- Company performance
- Company - annual report
- Company performance
- Company performance
- Company - distributor
- Company in Litigation
- Company growth
Order the CD ROM
Today
|